Novocell reports breakthrough in diabetes cure
Researchers at Novocell report a key breakthrough in their program to find a cure for diabetes. The company reports that the researchers were able to turn embryonic stem cells into insulin-producing cells in mice. And after the mice's insulin-producing cells had been destroyed, the new cells kept their blood sugar levels in check.
"For those who say there is not much evidence that embryonic stem cells can cure diabetes, there you go," Dr. Camillo Ricordi, director of the Diabetes Research Institute at the University of Miami told The New York Times. Dr. Ricordi was not involved in the research program. The research did raise red flags, though. Some of the mice in the study developed tumors and there were questions raised whether the cells were characterized well enough for use in humans. Human trials are still several years away.
- read the article in The New York Times
Related Articles:
Novocell garners $25M for stem cell work. Report
Novocell scientists create insulin-producing cells. Report
ESC therapies in race to the clinic. Report
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


